These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15663581)

  • 1. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation.
    Buhimschi IA; Christner R; Buhimschi CS
    BJOG; 2005 Feb; 112(2):173-81. PubMed ID: 15663581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis.
    Buhimschi CS; Bhandari V; Hamar BD; Bahtiyar MO; Zhao G; Sfakianaki AK; Pettker CM; Magloire L; Funai E; Norwitz ER; Paidas M; Copel JA; Weiner CP; Lockwood CJ; Buhimschi IA
    PLoS Med; 2007 Jan; 4(1):e18. PubMed ID: 17227133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis.
    Buhimschi IA; Zambrano E; Pettker CM; Bahtiyar MO; Paidas M; Rosenberg VA; Thung S; Salafia CM; Buhimschi CS
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):403-12. PubMed ID: 18238979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth.
    Buhimschi CS; Dulay AT; Abdel-Razeq S; Zhao G; Lee S; Hodgson EJ; Bhandari V; Buhimschi IA
    BJOG; 2009 Jan; 116(2):257-67. PubMed ID: 18947340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth.
    Buhimschi IA; Zhao G; Rosenberg VA; Abdel-Razeq S; Thung S; Buhimschi CS
    PLoS One; 2008 Apr; 3(4):e2049. PubMed ID: 18431506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profiling.
    Romero R; Espinoza J; Rogers WT; Moser A; Nien JK; Kusanovic JP; Gotsch F; Erez O; Gomez R; Edwin S; Hassan SS
    J Matern Fetal Neonatal Med; 2008 Jun; 21(6):367-88. PubMed ID: 18570116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers.
    Gravett MG; Novy MJ; Rosenfeld RG; Reddy AP; Jacob T; Turner M; McCormack A; Lapidus JA; Hitti J; Eschenbach DA; Roberts CT; Nagalla SR
    JAMA; 2004 Jul; 292(4):462-9. PubMed ID: 15280344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.
    Romero R; Kadar N; Miranda J; Korzeniewski SJ; Schwartz AG; Chaemsaithong P; Rogers W; Soto E; Gotsch F; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2014 May; 27(8):757-69. PubMed ID: 24028673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of midtrimester amniotic fluid to identify novel biomarkers for preterm delivery.
    Fotopoulou C; Kyeyamwa S; Linder M; Thieme D; Hartenstein S; Klein O; Dudenhausen JW; Henrich W; Kalache KD; Bamberg C
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2488-93. PubMed ID: 22827563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form.
    Buhimschi IA; Buhimschi CS; Weiner CP; Kimura T; Hamar BD; Sfakianaki AK; Norwitz ER; Funai EF; Ratner E
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):837-44. PubMed ID: 16002632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry.
    Bujold E; Romero R; Kusanovic JP; Erez O; Gotsch F; Chaiworapongsa T; Gomez R; Espinoza J; Vaisbuch E; Mee Kim Y; Edwin S; Pisano M; Allen B; Podust VN; Dalmasso EA; Rutherford J; Rogers W; Moser A; Yoon BH; Barder T
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):697-713. PubMed ID: 19012186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of amniotic fluid inflammatory biomarkers for subclinical chorioamnionitis.
    Liu Y; Liu Y; Du C; Zhang R; Feng Z; Zhang J
    Int J Gynaecol Obstet; 2016 Aug; 134(2):160-4. PubMed ID: 27177518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.
    Rüetschi U; Rosén A; Karlsson G; Zetterberg H; Rymo L; Hagberg H; Jacobsson B
    J Proteome Res; 2005; 4(6):2236-42. PubMed ID: 16335971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An elevated amniotic fluid prostaglandin F2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.
    Park JY; Romero R; Lee J; Chaemsaithong P; Chaiyasit N; Yoon BH
    J Matern Fetal Neonatal Med; 2016; 29(16):2563-72. PubMed ID: 26669519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation.
    Romero R; Kusanovic JP; Gotsch F; Erez O; Vaisbuch E; Mazaki-Tovi S; Moser A; Tam S; Leszyk J; Master SR; Juhasz P; Pacora P; Ogge G; Gomez R; Yoon BH; Yeo L; Hassan SS; Rogers WT
    J Matern Fetal Neonatal Med; 2010 Apr; 23(4):261-80. PubMed ID: 19670042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes.
    Chaemsaithong P; Romero R; Korzeniewski SJ; Martinez-Varea A; Dong Z; Yoon BH; Hassan SS; Chaiworapongsa T; Yeo L
    J Matern Fetal Neonatal Med; 2016; 29(3):349-59. PubMed ID: 25758618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low amniotic fluid glucose levels are a specific but not a sensitive marker for subclinical intrauterine infections in patients in preterm labor with intact membranes.
    Greig PC; Ernest JM; Teot L
    Am J Obstet Gynecol; 1994 Aug; 171(2):365-70; discussion 370-1. PubMed ID: 8059814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection.
    Chaemsaithong P; Romero R; Korzeniewski SJ; Martinez-Varea A; Dong Z; Yoon BH; Hassan SS; Chaiworapongsa T; Yeo L
    J Matern Fetal Neonatal Med; 2016; 29(3):360-7. PubMed ID: 25758620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.
    Oh KJ; Romero R; Park JY; Lee J; Conde-Agudelo A; Hong JS; Yoon BH
    Am J Obstet Gynecol; 2019 Aug; 221(2):140.e1-140.e18. PubMed ID: 30928565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.
    Yoon BH; Romero R; Park JY; Oh KJ; Lee J; Conde-Agudelo A; Hong JS
    Am J Obstet Gynecol; 2019 Aug; 221(2):142.e1-142.e22. PubMed ID: 30928566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.